Surgery To foster collaboration between ESSO and EORTC An opportunity to do a prospective study for liver metastasis surgery To answer important questions: Is surgery truly beneficial for initially unresectable CRLM patients? How can we improve surgical strategies? What quality indicators can we use to improve patient care? 2
Head of the Digestive Tumors Unit • Institut Bergonié • ESSO Clinical Research Director • Co-coordinator • Graeme Poston • Hepatobiliary Center • Aintree University Hospital • ESSO President • Clinical Research Fellow • Carmela Isabel Caballero, MD (EORTC) 4
with unresectable or initially unresectable liver metastasis who are potential candidates for a surgical procedure • Patient must be discussed within a multidisciplinary tumor board before surgery. 5
surgical strategies for initially unresectable liver metastasis from colorectal cancer. • Develop thresholds for quality parameters for different surgical strategies for initially unresectable liver metastases from colorectal cancer. 6
patients with CRLM who undergo different treatment strategies • Determine the short-term impact of participating in a database in terms of improved complication rates among participating institutions 7
of the protocol and the database • Selection and activation of the participating institutions • Development of the infrastructure 1st analysis • Review of the data, benchmarking for Quality parameters • Identification of the source of errors • Selection of targets for improvement • Development of an action plan to improve the selected targets • Analyses of short-term outcome (DFS, PFS) Implementation phase • Implementation of processes to improve predefined targets 2nd analysis • Review of the data, benchmarking • Analysis of the impact of implemented processes on the targets • Analyses of outcome (DFS, PFS, OS)